| 1 | Creatine Monohydrate Sourcing | A supplier should identify the incoming creatine monohydrate material and maintain traceability from receipt through production. Creatine monohydrate has the formula C4H9N3O2·H2O. | Raw-material specification, lot-specific certificate of analysis, supplier qualification records, and traceability documentation. |
| 2 | Encapsulation Process Selection | Encapsulation may use techniques such as fluid-bed coating, spray drying, or granulation, depending on the formulation and intended product properties. The process should be described rather than assumed from the word “encapsulated.” | Process flow, equipment description, batch record, and explanation of how the chosen process forms the coating or matrix. |
| 3 | Coating or Matrix Control | Encapsulating materials can include selected polymers, lipids, or carbohydrate-based materials. Their identity and quantity affect the finished product and should be controlled against the approved formulation. | Formulation record, ingredient specifications, approved change-control records, and finished-product composition data. |
| 4 | In-Process Uniformity | Mixing, coating, drying, and sizing steps can influence batch consistency. In-process controls should be selected for the specific equipment and formulation. | In-process monitoring records, defined sampling plan, batch-to-batch review, and documented investigation of deviations. |
| 5 | Identity and Creatine Assay | Identity testing confirms that the material is the intended compound; assay testing measures creatine content. A validated chromatographic method, such as an appropriate HPLC method, may be used when suitable for the product matrix. | Test method and validation or verification records, representative chromatograms where applicable, and lot-specific results against the agreed specification. |
| 6 | Moisture and Water Activity | Moisture can affect powder handling and stability. Loss on drying or Karl Fischer titration may be used to measure moisture, while water activity provides a separate measure of water available for reactions or microbial growth. | Method-specific results, instrument calibration records, and documented limits established for the product. |
| 7 | Particle Size and Physical Properties | Particle-size distribution, bulk density, and flow behavior can affect blending, filling, and product performance. Laser diffraction is one method that may be used for particle-size analysis. | Defined sampling and test procedures, particle-size distribution results, and physical-property data from representative production lots. |
| 8 | Encapsulation Performance | Encapsulation efficiency and release or dissolution behavior are formulation-dependent. These properties require suitable, product-specific methods; results should not be compared unless the methods and conditions are comparable. | Written test protocol, method suitability or validation data, defined test conditions, and results linked to the finished-product specification. |
| 9 | Microbiological and Contaminant Controls | Risk-based testing may include specified microbial limits and testing for relevant elemental contaminants. ICP-MS is one technique used for elemental analysis; applicable requirements vary by market and product category. | Laboratory reports, methods and reporting limits, risk assessment, and compliance documentation for the intended sales market. |
| 10 | Packaging, Stability, and Lot Release | Packaging should protect the powder from relevant environmental exposure. Stability testing under defined conditions can support shelf-life claims, and each lot should be reviewed against its approved release specifications. | Packaging specifications, stability protocol and supporting data, batch-release record, certificate of analysis, and documented change control. |